How much alpha-GPC do studies and labels give?

Strengths and forms
FormStrengthListed in
Soft capsule400 mgEMA list;4 Gliatilin leaflet1
Capsule; flaconciniGliatilin 600 capsule; Gliatilin 600 mg flaconciniEMA list, Italy4
Tablet400 mg film-coated test tablet; 250 mg trial tabletsBioequivalence study;5 NCT028861303
Oral solution600 mg/7 mlItaly (Delecit)4
Injection solutionGliatilin 1000 mg/4 ml (250 mg/ml), Poland; Gliatilin 1000mg/4ml, Italy; Delecit 1000 mg, Italy (volume not listed)EMA list4

The Gliatilin leaflet gives one 400 mg capsule per dose, and the trials below range from 250 mg for 7 days to 1000 mg a day for 4 weeks per arm.123

Strengths and forms

The table is set at the top of the page

EFSA says choline alfoscerate is sold in Italy and Poland as capsules or as an injection solution at a maximum dose of 1000 mg.6 The Gliatilin leaflet, written for degenerative brain conditions in older people, gives one 400 mg capsule per dose, with two or three doses daily, which the doctor may increase.1

What labels and regulators give

EFSA's novel-food opinion records the applicant's proposed maximum of 203.7 mg a day of L-alpha-GPC in food supplements (82.5 mg a day of choline), for people above 3 years of age, including pregnant and lactating women.6 A search of DailyMed found no US label for alpha-GPC. Kerksick and Marcus each tested two doses side by side, but the sources searched include no dose-finding trial.72

What human trials gave

TrialDose and schedulePeopleLength
Kerksick (crossover)315 mg or 630 mg, or placebo, tested 60 min after ingestion720 resistance-trained menOne dose per visit
Bellar (crossover)600 mg a day or placebo, morning and evening, one-week washout813 healthy college-aged men6 days
Marcus500 mg or 250 mg A-GPC, against 200 mg caffeine or placebo, two capsules per day2Forty-eight healthy college-aged men7 days
Jeon600 mg soft capsule or placebo, once daily with water9100 adults aged 55 to 85 with mild cognitive impairment (52 on alpha-GPC, 48 on placebo)12 weeks
NCT02886130 (crossover)2 x 250 mg in the morning and 2 x 250 mg 60 min before workout, or placebo, 7-day washout328 volleyball players4 weeks per arm
NCT07267845350 mg capsule (315 mg alpha-GPC) or placebo, once daily before breakfast1081 healthy adults aged 25-55 enrolled (80 planned)6 weeks, daily

Timing and mixing

Kerksick tested people 60 min after the dose, taken with about 12 fluid ounces of water.7 In Marcus's trial the first dose came with 237 ml of cool water and the next 6 days of doses were taken in the morning.2 Kerksick's introduction cites a conference report by Ziegenfuss and colleagues in which seven healthy men took a single 600 mg dose or placebo 90 min before lower-body exercise.7

No leaflet or maker text in the sources gives mixing directions or a water volume for alpha-GPC powder. EFSA describes Alpha Size 100P, the powder form of the novel food it assessed, as a white to off-white crystalline powder, highly soluble in water.6

Daily use, cycles and safety

In Jeon's 12-week trial in adults with mild cognitive impairment, no serious adverse events were reported on 600 mg, and the commonest in both groups were gastrointestinal.9 The sources searched give no on-and-off cycling schedule.

Long-term safety

A Korean cohort compared 81,970 alpha-GPC users aged 50 or over with 409,801 non-users and found no link with kidney cancer (adjusted HR 0.95, 95% CI 0.84-1.08); its background notes that the oncologic safety of supplemental alpha-GPC remains uncertain.11 A paper of mainly mouse and cell work, not a human dose study, cites a cohort of more than 12 million people in which GPC was linked to a higher 10-year incident stroke risk in a dose-response manner.12 EFSA concluded the novel food does not raise safety concerns under the proposed conditions of use (203.7 mg/day), and notes that most human studies submitted were run at 1200 mg a day for up to 6 months in male and female older adults.6

Storage

The Gliatilin leaflet says to store the capsules below 30°C.1 In Min and colleagues' bioequivalence study, the 400 mg film-coated tablet and the reference soft capsule were kept 3 months at 40°C/75% RH; the tablet's appearance is listed as no change and the capsule's as deform.5 The sources searched hold no stability data for a mixed alpha-GPC solution.

Frequently asked questions

Is alpha-GPC given by mouth or by injection?

The Gliatilin leaflet gives soft gelatin capsules for oral use,1 and every trial in the table above gave alpha-GPC by mouth.7289310 Kerksick's paper reviews an earlier study in which 32 healthy young volunteers received an intramuscular injection of 1000 mg A-GPC or placebo for ten days.7 Gatti and colleagues gave 12 normal volunteers a single 1,000 mg intramuscular dose of alpha-GPC, compared with 1,000 mg of intramuscular citicoline and a control day, with at least 1 week between sessions.13

How many mg are in a mL of liquid alpha-GPC?

The EMA list gives Gliatilin injection solution as 250 mg/ml (1000 mg/4 ml), in Poland and Italy.4 The Italian oral solution is 600 mg/7 ml, and none of the sources searched gives a syringe mark for alpha-GPC.4

References

  1. Italfarmaco (leaflet). Foglio illustrativo: informazioni per il paziente. farmasave.it
  2. PMC. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. 2017. pmc.ncbi.nlm.nih.gov
  3. ClinicalTrials.gov. NCT02886130: Alpha-GPC and Physical and Cognitive Performances in Volleyball Players. 2016. clinicaltrials.gov
  4. EMA. choline alfoscerate: List of nationally authorsied medicinal products - PSUSA/00010599/202208. ema.europa.eu
  5. PMC. Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers. 2019. pmc.ncbi.nlm.nih.gov
  6. EFSA. Safety of L‐alpha‐glycerylphosphorylcholine (L‐alpha‐ GPC ) from soya phospholipids (lecithin) as a novel food pursuant to Regulation ( EU ) 2015/2283. 2026. pmc.ncbi.nlm.nih.gov
  7. PMC. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. 2024. pmc.ncbi.nlm.nih.gov
  8. PMC. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. 2015. pmc.ncbi.nlm.nih.gov
  9. PMC. Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial. 2024. pmc.ncbi.nlm.nih.gov
  10. ClinicalTrials.gov. NCT07267845: The Effect of α-GPC on Cognitive Function and Sports Performance. 2026. clinicaltrials.gov
  11. PubMed. Association between L-α-glycerylphosphorylcholine use and risk of kidney cancer: A nationwide representative retrospective cohort study. 2026. pubmed.ncbi.nlm.nih.gov
  12. PMC. The Nutritional Supplement L -Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. 2021. pmc.ncbi.nlm.nih.gov
  13. PubMed. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. 1992. pubmed.ncbi.nlm.nih.gov